The Journal of the Korean bone and joint tumor society (대한골관절종양학회지)

The Korean Musculoskeletal Tumor Society (대한근골격종양학회)
권호 표지
DOI QR코드

DOI QR Code

Treatment Outcomes of Sacral Giant Cell Tumor

천골 거대 세포종의 치료 결과

  • Kong, Chang-Bae (Department of Orthopedic Surgery, Korea Cancer Center Hospital) ;
  • Lee, Kwang-Youl (Department of Orthopedic Surgery, Korea Cancer Center Hospital) ;
  • Song, Won-Seok (Department of Orthopedic Surgery, Korea Cancer Center Hospital) ;
  • Cho, Wan Hyeong (Department of Orthopedic Surgery, Korea Cancer Center Hospital) ;
  • Koh, Jae-Soo (Department of Pathology, Korea Cancer Center Hospital) ;
  • Jeon, Dae-Geun (Department of Orthopedic Surgery, Korea Cancer Center Hospital) ;
  • Lee, Soo-Yong (Department of Orthopedic Surgery, Korea Cancer Center Hospital)
  • Received : 2013.10.21
  • Accepted : 2013.11.28
  • Published : 2013.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: We analyzed the treatment outcomes of patients with sacral giant cell tumor. Materials and Methods: We retrospectively reviewed 7 patients with giant cell tumor of the sacrum who were treated at out institution between 1990 and 2012. Results: There were 2 men and 5 women with mean age of 23.6 years. The average follow up was 52.3 months (range, 15-73 months). Six patients received surgical treatment. Intralesional curettage was performed for the 5 patients and marginal resection for another one patient. The remaining one patient was received radiation only. The patients who received radiation therapy and marginal excision had no residual or recurrent tumors. Of 5 patients with intra-lesional excision, one patient needs one more operation; two patients need two more operation for local control of the giant cell tumor. The remaining two patients failed to gain local control in spite of additional treatments. Conclusion: For the treatment of sacral giant cell tumor, intralesional resection can be one of the treatments option with minimal neurologic injury. Furthermore, radiation therapy can be recommended when complete excision or curettage is impractical.

목적: 천골에 발생하는 드문 질환인 거대 세포종의 치료 방법에 따른 특성과 예후에 대하여 알아보고자 하였다. 대상 및 방법: 1990년부터 2012년까지 천골의 거대 세포종으로 진단받고 본원에서 치료받은 7명의 환자를 대상으로 하였다. 결과: 평균 연령은 23.6세였고, 남자가 2예, 여자가 5예였으며 평균 추시 기간은 52.3개월(15-73개월)이었다. 5명의 환자에서 병소내 절제술을, 1명의 환자에서 변연 절제술을 시행하였으며 수술적 치료를 시행하지 않은 1명은 방사선 치료만 시행하였다. 방사선 치료만을 시행한 환자와 변연 절제술을 시행한 환자는 국소 재발 없이 추시 중이다. 그 외 병소내 절제를 시행한 5명 중 1예는 한 번의 수술로, 다른 두 예는 두 차례 수술 후 재발 없이 추시 관찰 중이다. 나머지 두 예는 추가 치료에도 병변의 진행을 보였다. 결론: 천골 거대 세포종 환자의 치료법으로써 병소내 절제는 신경학적 손상을 최소화하면서 종양을 치료할 수 있는 방법 중 하나가 될 것으로 판단된다. 또한, 수술적 치료가 어려운 경우 방사선 치료가 대안으로 사용될 수 있다고 생각된다.

Keywords

References

  1. Sung HW, Shu WP, Wang HM, Yuai SY, Tsai YB. Surgical treatment of primary tumors of the sacrum. Clin Orthop Relat Res. 1987;(215):91-8.
  2. Turcotte RE. Giant cell tumor of bone. Orthop Clin North Am. 2006;37:35-51. https://doi.org/10.1016/j.ocl.2005.08.005
  3. Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg Am. 1987;69:106-14.
  4. Feigenberg SJ, Marcus Jr RB, Zlotecki RA, Scarborough MT, Berrey BH, Enneking WF. Radiation therapy for giant cell tumors of bone. Clin Orthop Relat Res. 2003;(411):207-16.
  5. McDonald DJ, Sim FH, McLeod RA, Dahlin DC. Giant-cell tumor of bone. J Bone Joint Surg Am. 1986;68:235-42. https://doi.org/10.2106/00004623-198668020-00009
  6. Sung HW, Kuo DP, Shu WP, Chai YB, Liu CC, Li SM. Giant-cell tumor of bone: analysis of two hundred and eight cases in Chinese patients. J Bone Joint Surg Am. 1982;64:755-61. https://doi.org/10.2106/00004623-198264050-00015
  7. Guo W, Ji T, Tang X, Yang Y. Outcome of conservative surgery for giant cell tumor of the sacrum. Spine (Phila Pa 1976). 2009;34:1025-31. https://doi.org/10.1097/BRS.0b013e31819d4127
  8. Leggon RE, Zlotecki R, Reith J, Scarborough MT. Giant cell tumor of the pelvis and sacrum: 17 cases and analysis of the literature. Clin Orthop Relat Res. 2004;(423):196-207.
  9. Thangaraj R, Grimer RJ, Carter SR, Stirling AJ, Spilsbury J, Spooner D. Giant cell tumour of the sacrum: a suggested algorithm for treatment. Eur Spine J. 2010;19:1189-94. https://doi.org/10.1007/s00586-009-1270-8
  10. Martin C, McCarthy EF. Giant cell tumor of the sacrum and spine: series of 23 cases and a review of the literature. Iowa Orthop J. 2010;30:69-75.
  11. Rock MG, Sim FH, Unni KK, et al. Secondary malignant giant-cell tumor of bone. Clinicopathological assessment of nineteen patients. J Bone Joint Surg Am. 1986;68:1073-9. https://doi.org/10.2106/00004623-198668070-00016
  12. Laskin WB, Silverman TA, Enzinger FM. Postradiation soft tissue sarcomas. An analysis of 53 cases. Cancer. 1988;62:2330-40. https://doi.org/10.1002/1097-0142(19881201)62:11<2330::AID-CNCR2820621113>3.0.CO;2-2
  13. Dray MS, Miller MV. Paget's osteosarcoma and post-radiation osteosarcoma: secondary osteosarcoma at Middlemore Hospital, New Zealand. Pathology. 2008;40:604-10. https://doi.org/10.1080/00313020802320663
  14. Kong CB, Hong YS, Lee KY, et al. Malignant transformation of benign giant cell tumor. J Korean Bone Joint Tumor Soc. 2012;18:14-9. https://doi.org/10.5292/jkbjts.2012.18.1.14
  15. Lackman RD, Khoury LD, Esmail A, Donthineni-Rao R. The treatment of sacral giant-cell tumours by serial arterial embolisation. J Bone Joint Surg Br. 2002;84:873-7. https://doi.org/10.1302/0301-620X.84B6.13178
  16. Hosalkar HS, Jones KJ, King JJ, Lackman RD. Serial arterial embolization for large sacral giant-cell tumors: mid- to longterm results. Spine (Phila Pa 1976). 2007;32:1107-15. https://doi.org/10.1097/01.brs.0000261558.94247.8d
  17. Bertoni F, Present D, Sudanese A, Baldini N, Bacchini P, Campanacci M. Giant-cell tumor of bone with pulmonary metastases. Six case reports and a review of the literature. Clin Orthop Relat Res. 1988;(237):275-85.
  18. Thomas D, Henshaw R, Skubitz K, et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol. 2010;11:275-80. https://doi.org/10.1016/S1470-2045(10)70010-3
  19. Branstetter DG, Nelson SD, Manivel JC, et al. Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone. Clin Cancer Res. 2012;18:4415-24. https://doi.org/10.1158/1078-0432.CCR-12-0578